// App-Quantinova.ai

FRI0280 : STRUCTURAL PROGRESSION OF ANKYLOSING SPONDYLITIS ASSOCIATED WITH ELEVATION IN TWO NOVEL, INFLAMMATORY BIOMARKERS; MATRIX METALLOPROTEINASE AND CATHEPSIN-DERIVED CRP

Researchers

Presenter

  • A.C. Bay-Jensen

Principal Investigators

  • M.A. Karsdal

  • D.J. Leeming

  • S. Wichuk

  • W.P. Maksymowych

  • P. Qvist

Medical Centers

  • Division of Rheumatology, University of Alberta, Alberta, Canada

Locations

  • Canada

Companies

  • Nordic Bioscience A/

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Ankylosing spondylitis

  • Spondyloarthritis

Biomarkers

  • High sensitivity C-reactive protein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved